Used in pharmaceutical research as a key intermediate for developing central nervous system (CNS) active compounds, particularly serotonin and dopamine receptor modulators. Shows potential in the synthesis of agents targeting neurological disorders such as depression, anxiety, and Parkinson’s disease. Its chiral pyrrolidine structure enhances binding selectivity, making it valuable in optimizing drug efficacy and reducing off-target effects. Also employed in structure-activity relationship (SAR) studies to improve metabolic stability and bioavailability in novel therapeutics.